Repligen Corp. (RGEN)
137.22
-0.89
(-0.64%)
USD |
NASDAQ |
Feb 19, 16:00
137.23
+0.01
(+0.01%)
After-Hours: 20:00
Repligen Price : 137.22 for Feb. 19, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Abbott Laboratories | 112.19 |
| Accuray, Inc. | 0.5523 |
| Alphatec Holdings, Inc. | 13.48 |
| Boston Scientific Corp. | 75.72 |
| Plus Therapeutics, Inc. | 0.2928 |
Price Related Metrics
| PE Ratio | 5318.60 |
| PS Ratio | 10.94 |
| Price to Book Value | 3.708 |
| Price to Free Cash Flow | 74.81 |
| Earnings Yield | 0.02% |
| Market Cap | 7.724B |
| Operating PE Ratio | 165.70 |
| Normalized PE Ratio | 228.51 |